Companies To Watch

Companies To Watch: Imunon

Imunon aims to shake up the standard of care in the frontline treatment of advanced ovarian cancer.

Companies To Watch: Senti Bio

Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of identifying cancer targets on both healthy and diseased cells.

Companies To Watch: Terns Pharmaceuticals

Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small molecules.

Companies To Watch: Spinogenix

Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, glaucoma, and Fragile X syndrome.

Companies To Watch: Aurion Biotech

Aurion Biotech is developing what could become the first allogeneic combination cell therapy for the treatment of corneal endothelial diseases.

Companies To Watch: Athira Pharma

Athira Pharma is developing small molecule therapeutics for neurodegenerative diseases, including its lead candidate, fosgonimeton, for Alzheimer's disease.

Companies To Watch: Volastra Therapeutics

Volastra Therapeutics is a drug discovery and development leader in the emerging field of chromosomal instability, a phenomenon that can determine how certain solid tumor cancer cells replicate and grow.

Companies To Watch: OSE Immunotherapeutics

OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.

Companies To Watch: Antiva Biosciences

Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.

Companies to Watch: Promontory Therapeutics

A novel small molecule developer aims to shake up the solid tumor treatment landscape.

Companies To Watch: KeifeRx

Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.

Companies To Watch: Freya Biosciences

Freya Biosciences is enlivening the long-time lonely space of reproductive health, starting with a new focus on the vaginal microbiome.

Companies To Watch: Spruce Biosciences

Spruce Biosciences is currently in mid-to-late stage clinical development of new agents to treat rare endocrine disorders.

Companies To Watch: Nido Biosciences

See why Nido Biosciences is developing small molecule drugs for rare neurodegenerative diseases.